Reassessment of ATC-groups C01, C04 and C05

18 December 2006

At its meeting on 19 September 2006 , the Reimbursement Committee had its first discussion of the reimbursement status of the following ATC groups:

  • Medicinal products for cardiac therapy (C01)
  • Peripheral vasodilators (C04)
  • Vasoprotectives (C05)

In the fact box to your right, you can find a link to the documents from the Reimbursement Committee meetings (in Danish only).

For further information, please contact the Reimbursement Department, medicintilskud@dkma.dk.

The Danish Medicines Agency, 6 October 2006

 

 

 

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.


...